These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6642653)

  • 21. Apoptosis of primary sensory neurons in GD1b-induced sensory ataxic neuropathy.
    Takada K; Shimizu J; Kusunoki S
    Exp Neurol; 2008 Jan; 209(1):279-83. PubMed ID: 17964572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 4-Aminopyridine ameliorates experimental autoimmune neuritis in Lewis rats.
    Moriguchi K; Miyamoto K; Kusunoki S
    J Neuroimmunol; 2017 Apr; 305():72-74. PubMed ID: 28284349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral nervous system demyelination from systemic transfer of experimental allergic neuritis serum.
    Harvey GK; Pollard JD
    J Neuroimmunol; 1992 Dec; 41(2):159-66. PubMed ID: 1334966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [COMPARATIVE IMMUNOGENICITY STUDIES OF ADJUVANTS FROM VARIOUS SOURCES AND WITH DIFFERENT MECHANISMS OF ACTION FOR INACTIVATED INFLUENZA VACCINES].
    Chernikova MI; Kashirina OS; Vasiliev YM
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (6):63-71. PubMed ID: 26950991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of experimental allergic neuritis with nedocromil sodium.
    Seeldrayers PA; Yasui D; Weiner HL; Johnson D
    J Neuroimmunol; 1989 Dec; 25(2-3):221-6. PubMed ID: 2479661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Membrane attack complex of complement is not essential for immune mediated demyelination in experimental autoimmune neuritis.
    Tran GT; Hodgkinson SJ; Carter NM; Killingsworth M; Nomura M; Verma ND; Plain KM; Boyd R; Hall BM
    J Neuroimmunol; 2010 Dec; 229(1-2):98-106. PubMed ID: 20850187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants.
    WAKSMAN BH; ADAMS RD
    J Exp Med; 1955 Aug; 102(2):213-36. PubMed ID: 13242745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early myelin lesions in experimental allergic neuritis.
    Rosen JL; Brown MJ; Hickey WF; Rostami A
    Muscle Nerve; 1990 Jul; 13(7):629-36. PubMed ID: 2388663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [PATHOMORPHOLOGICAL CHANGES IN THE NERVOUS SYSTEM OF RABBITS IN EXPERIMENTAL ALLERGIC POLYNEURITIS].
    ZHABOTINSKII IuM; KHAI LM
    Arkh Patol; 1964; 26():19-25. PubMed ID: 14222170
    [No Abstract]   [Full Text] [Related]  

  • 30. In vivo monoclonal antibody treatment with Ox19 (anti-rat CD5) causes disease relapse and terminates P2-induced immunospecific tolerance in experimental allergic neuritis.
    Strigård K; Larsson P; Holmdahl R; Klareskog L; Olsson T
    J Neuroimmunol; 1989 Jun; 23(1):11-8. PubMed ID: 2470777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfer of experimental allergic neuritis by intra neural injection of sensitized lymphocytes.
    Hodgkinson SJ; Westland KW; Pollard JD
    J Neurol Sci; 1994 May; 123(1-2):162-72. PubMed ID: 8064309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. 2. SHORT-TERM ANIMAL TOXICITY TESTS.
    PECK HM; WOODHOUR AF; METZGAR DP; MCKINNEY SE; HILLEMAN MR
    Proc Soc Exp Biol Med; 1964 Jun; 116():523-30. PubMed ID: 14193391
    [No Abstract]   [Full Text] [Related]  

  • 33. Lipid-free versus lipid-bound P2 protein-induced experimental allergic neuritis: clinicopathological, neurophysiological, and immunological study.
    Cavaletti G; Matà S; Fasano A; Lolli F; Riccio P; Celon S; Marmiroli P; Tredici G
    J Neurosci Res; 2000 Dec; 62(5):709-16. PubMed ID: 11104509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-galactocerebroside antibody in rabbits with experimental allergic neuritis.
    Irie H; Yorita T; Takahashi K
    Jpn J Exp Med; 1986 Apr; 56(2):43-9. PubMed ID: 2426483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome.
    Nachamkin I; Shadomy SV; Moran AP; Cox N; Fitzgerald C; Ung H; Corcoran AT; Iskander JK; Schonberger LB; Chen RT
    J Infect Dis; 2008 Jul; 198(2):226-33. PubMed ID: 18522505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies to P2 and P1 myelin antigens in experimental allergic neuritis and allergic encephalomyelitis.
    Zweiman B; Moskovitz AR; Rostami A; Lisak RP; Pleasure DE; Brown MJ
    J Neuroimmunol; 1982 Jun; 2(3-4):331-6. PubMed ID: 6177713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Aspects of the etiopathogenesis of experimental allergic neuritis].
    Varsik P
    Cesk Neurol Neurochir; 1980 May; 43(3):148-54. PubMed ID: 7397866
    [No Abstract]   [Full Text] [Related]  

  • 38. Induction of allergic neuritis in rhesus monkeys.
    Eylar EH; Toro-Goyco E; Kessler MJ; Szymanska I
    J Neuroimmunol; 1982 Oct; 3(2):91-8. PubMed ID: 6181093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Administration of dehydroepiandrosterone ameliorates experimental autoimmune neuritis in Lewis rats.
    Tan XD; Dou YC; Shi CW; Duan RS; Sun RP
    J Neuroimmunol; 2009 Feb; 207(1-2):39-44. PubMed ID: 19174309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunity to influenza in ferrets. II. Influence of adjuvants on immunization.
    Potter CW; Shore SL; McLaren C; Stuart-Harris C
    Br J Exp Pathol; 1972 Apr; 53(2):168-79. PubMed ID: 4338059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.